… vaccines must provide a direct protective benefit to the vaccinee. The endpoint for SARS-CoV-2
vaccine … a proportion of vaccinated people, vaccination programs can also indirectly …

… health care workers received the first dose within 5 days of the initiation of the vaccination
program and 75% within 12 days. Eighty percent of first dose recipients received the second …

… As the implementations of SARS-CoV-2 vaccination programs evolve in several countries
around the world, governments must decide how to allocate doses among the population …

… vaccine development process against SARS-CoV-2, including 1) potential antigen targets 2)
different vaccination … is necessary especially during the mass vaccination program as ADE …

… unvaccinated-only screening programs, we introduce a model for SARS-CoV-2 transmission
… rates, vaccine effectiveness scenarios, rates of prior infection, and screening programs. We …

… vaccination status; however, by July, no differences were detected among specimens from
fully vaccinated, partially vaccinated, … authorized vaccines were protective against SARS-CoV-…

… Antibody therapy, mass vaccination programs, and antiviral drugs are regarded as the
most effective measures. However, even though numerous antiviral drugs are currently in …

… Productive vaccine programs under accelerated studies and clinical trials indeed relieve
the anxiety for possible upcoming of another ‘Spanish influenza’ in the 21st century. However, …

… The MHRA (United Kingdom) was the first regulatory body to give EMU for Pfizer-BioNTech
mRNA vaccine (BNT162b2) in the vaccination program of the UK for healthcare staff and the …

… the model to incorporate two vaccinated classes, corresponding to individuals who have
received either one dose or two doses of a SARS-CoV-2 vaccine. As with natural immunity, we …